| |
| |
|
| Insider
Information: |
Fyrwald J Erik |
| Relationship: |
Officer, Director |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
465,312 |
|
|
Indirect Shares
|
819,344 |
|
|
| Direct
Value |
$95,325,589 |
|
|
|
Indirect Value
|
$41,580,918 |
|
|
| Total
Shares |
1,284,656 |
|
|
| Total
Value |
$136,906,507 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 29.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
Director |
2023-12-18 |
71,886 |
|
0 |
Premium* |
|
|
Nalco Holding Co |
NLC |
Chairman, President, CEO |
2011-12-01 |
0 |
2008-03-07 |
0 |
Premium* |
|
|
Ecolab Inc |
ECL |
President |
2012-02-28 |
129,824 |
2012-02-28 |
49,402 |
Premium* |
|
|
Univar Inc. |
UNVR |
Chief Executive Office... |
2015-09-30 |
251,953 |
2015-09-30 |
735,514 |
Premium* |
|
|
Bunge Ltd |
BG |
Director |
2023-03-02 |
7,349 |
2023-03-02 |
23,138 |
Premium* |
|
|
International Flavors & Fragranc... |
IFF |
Officer, Director |
2024-02-06 |
4,300 |
2024-02-06 |
11,290 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
Director |
– • – |
2013-11-29 |
4 |
A |
$51.03 |
$144,976 |
D/D |
2,841 |
44,327 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2014-11-28 |
4 |
A |
$67.29 |
$145,010 |
D/D |
2,155 |
47,982 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2015-11-30 |
4 |
A |
$81.23 |
$144,996 |
D/D |
1,785 |
50,999 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2016-11-30 |
4 |
A |
$76.64 |
$160,024 |
D/D |
2,088 |
54,439 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2017-11-20 |
4 |
A |
$83.18 |
$160,038 |
D/D |
1,924 |
57,760 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2018-01-15 |
4 |
A |
$85.29 |
$5,459 |
D/D |
64 |
58,159 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2018-01-16 |
4/A |
A |
$85.29 |
$5,459 |
D/D |
64 |
58,159 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2018-02-20 |
4 |
A |
$77.55 |
$5,429 |
D/D |
70 |
58,229 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2018-03-19 |
4 |
A |
$78.57 |
$5,421 |
D/D |
69 |
58,708 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2018-04-16 |
4 |
A |
$80.12 |
$5,448 |
D/D |
68 |
58,776 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2018-05-21 |
4 |
A |
$81.83 |
$5,483 |
D/D |
67 |
58,843 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2018-06-18 |
4 |
A |
$86.11 |
$5,425 |
D/D |
63 |
59,289 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2018-07-16 |
4 |
A |
$89.07 |
$5,433 |
D/D |
61 |
59,350 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2018-08-20 |
4 |
A |
$105.82 |
$5,397 |
D/D |
51 |
59,401 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2018-09-17 |
4 |
A |
$105.71 |
$12,685 |
D/D |
120 |
59,834 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2018-10-15 |
4 |
A |
$110.62 |
$5,420 |
D/D |
49 |
59,883 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2018-11-19 |
4 |
A |
$115.81 |
$180,432 |
D/D |
1,558 |
61,441 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2018-12-17 |
4 |
A |
$108.36 |
$5,418 |
D/D |
50 |
61,694 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2019-11-18 |
4 |
A |
$114.07 |
$174,983 |
D/D |
1,534 |
64,254 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2020-11-16 |
4 |
A |
$140.59 |
$175,035 |
D/D |
1,245 |
66,818 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2021-11-15 |
4 |
A |
$258.43 |
$174,957 |
D/D |
677 |
68,564 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-01-18 |
4 |
A |
$247.07 |
$9,883 |
D/D |
40 |
68,842 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-02-22 |
4 |
A |
$239.13 |
$9,804 |
D/D |
41 |
68,883 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-03-21 |
4 |
A |
$289.64 |
$9,848 |
D/D |
34 |
69,170 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-04-18 |
4 |
A |
$298.82 |
$9,861 |
D/D |
33 |
69,203 |
0 |
- |
|
140 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
